Chengdu Shengnuo is one of the leading peptide manufacturers in China. There are 5 US-DMF of Peptide APIs: Liraglutide, Bivalirudin, Eptifibatide, Icatibant and Octreotide. The below US-DMFs will be submitted soon: Linaclotide, Degarelix, Teriparatide,Ziconotide,Exenatide and Ganirelix soon. Shengnuo also have a few Chinese GMP APIs: Atosiban,Carbetocin, Octreotide, Enfuvirtide,Thymalfasin, Somatostatin, Thymopentin and Levosimendan.Chengdu Shengnuo Biopharm Co Ltd is a subsidiary of Chengdu Shengnuo Tech Development Co Ltd and was founded in October 2004. With 50 key technologies for large-scale production of domestic and foreign peptide drugs, we are a leading manufacturer of peptides by solid-phase chemistry. In addition, our team has the ability to perform product development, technology transfer, technical services and large-scale multi-kilogram single batch production capacities. As an industry leader in the domestic solid-phase peptide market, we have recently received approval as a registered US FDA manufacturing facility with zero...
Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Categories affiliated with Chengdu Shengnuo Biopharm Co Ltd
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation